Brooke Worster, MD, MS, FACP, and chief medical officer at EO Care, details what oncologists should know about medical cannabis pending the expectant marijuana reclassification from a Schedule I to a Schedule III drug.
EO Care, a provider of clinically guided cannabis health and wellness solutions has been selected as the cannabis care content partner for the non-profit organization Twist Out Cancer.